NEW MILTON, UK & WASHINGTON, D.C.--(BUSINESS WIRE)--Genetix, a leading developer of technologies for automated, high throughput cell identification and selection for the pharmaceutical, biotechnology and clinical diagnostics industries, announces the expansion of its “CloneMedia” range of semi-solid media products for mammalian cell cloning. Launched at American Society of Cell Biology, in Washington DC, the two new products – CloneMedia-HEK and CloneMedia-CHOK1 – are designed for the semi-solid cloning of suspension-adapted, serum-free HEK293 and CHOK1 cells, respectively.
